SEPRACOR INC /DE/
8-K, 2000-03-16
PHARMACEUTICAL PREPARATIONS
Previous: SEPRACOR INC /DE/, SC 13G/A, 2000-03-16
Next: NEOSE TECHNOLOGIES INC, S-3/A, 2000-03-16



<PAGE>


                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549


                              --------------------

                                    FORM 8-K

                                 CURRENT REPORT

                     Pursuant to Section 13 or 15(d) of the
                         Securities Exchange Act of 1934

         Date of Report (Date of earliest event reported): March 8, 2000



                                  Sepracor Inc.
                                  -------------

             (Exact name of registrant as specified in its charter)

<TABLE>
<CAPTION>

            Delaware                                0-19410                           22-2536587
   ------------------------------          ------------------------       --------------------------------
<S>                                        <C>                            <C>

  (State or other jurisdiction of          (Commission File Number)       (IRS Employer Identification No.)
           incorporation)
</TABLE>

<TABLE>
<CAPTION>
          111 Locke Drive
          Marlborough, MA                                01757
- -------------------------------------           --------------------------------
<S>                                                   <C>

 (Address of principal executive                      (Zip Code)
              offices)
</TABLE>

       Registrant's telephone number, including area code: (508) 481-6700

                                       N/A
          -------------------------------------------------------------
          (Former name or former address, if changed since last report)


                                      -1-
<PAGE>



Item 5.    Other Events.

         On March 8, 2000, Sepracor Inc., a Delaware corporation (the
"Company), announced the exercise of the full $60 million over-allotment
option it had granted in connection with its $400 million offering of
Convertible Subordinated Debentures Due 2007. A copy of the press release is
attached to this Current Report on Form 8-K as Exhibit 99.1.

Item 7.    Financial Statements, Pro Forma Financial Information and Exhibits.

         (c)      Exhibits.

         See Exhibit Index attached hereto.


                                      -2-
<PAGE>


                                    SIGNATURE

         Pursuant to the requirements of the Securities Exchange Act of 1934, as
amended, the registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.

Date:    March 15, 2000                              SEPRACOR INC.



                                             By:  /s/ Robert F. Scumaci
                                                  ---------------------
                                                  Robert F. Scumaci
                                                  Senior Vice President, Finance
                                                  and Administration


                                      -3-
<PAGE>



                                  EXHIBIT INDEX

<TABLE>
<CAPTION>

Exhibit
  No.             Description
 ----             -----------
<S>               <C>

99.1              Press Release dated March 8, 2000.
</TABLE>


                                      -4-



<PAGE>


                                                                    EXHIBIT 99.1
                                                                    ------------
                                                                   Press Release

SEPRACOR OVER-ALLOTMENT OPTION EXERCISED IN FULL

MARLBOROUGH, Mass., March 8/PRNewswire/ -- Sepracor Inc. (Nasdaq: SEPR - NEWS)
today announced that it has been informed of the exercise of the full
over-allotment option associated with its $400 million offering of Convertible
Subordinated Debentures due 2007. Gross proceeds of the over-allotment option
are $60 million.

The Debentures have not been registered under the Securities Act of 1933 and may
not be offered or sold in the United States, except pursuant to an applicable
exemption from the Securities Act registration requirements.

This press release shall not constitute an offer to sell or the solicitation of
an offer to buy the Debentures. This press release is being issued pursuant to
and in accordance with Rule 135c under the Securities Act.

To receive a copy of this release or any recent release via fax, call Sepracor's
automated news fax line at 1-800-758-5804 ext. 780960, or visit the Company's
web site at WWW.SEPRACOR.COM.

Contacts:
    -   David P. Southwell
    -   Chief Financial Officer
    -   Sepracor Inc.
    -   Jonae R. Barnes
    -   Executive Director
    -   Investor Relations
    -   Sepracor Inc.
    -   (508) 481-6700


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission